Page last updated: 2024-08-23

pefloxacin and Community Acquired Infection

pefloxacin has been researched along with Community Acquired Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, CC; Ng, A; Poh, SC; Wang, YT; Yap, JC1
DvoretskiÄ­, LI; Iakovlev, SV; Shakhova, TV; Suvorova, MP1

Trials

2 trial(s) available for pefloxacin and Community Acquired Infection

ArticleYear
Evaluation of the efficacy of sequential intravenous-oral administration of pefloxacin in community-acquired lower respiratory tract infections in patients with underlying conditions.
    Singapore medical journal, 1995, Volume: 36, Issue:5

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pefloxacin; Respiratory Tract Infections; Treatment Outcome

1995
[Program of empirical antibacterial therapy of community-acquired pneumonia].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1998, Volume: 43, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Roxithromycin; Spiramycin

1998